Abstract. We examined the effects of treatment with histone deacetylase inhibitors (HDACi), trichostatin A (TSA) and scriptaid (SCR), on the blastocyst formation rate in bovine somatic cell nuclear transferred (SCNT) embryos derived from fibroblast cells. Three fibroblast cell lines (L1, L2 and L3) were used as somatic cell donors to produce SCNT embryos (L1, L2 and L3 embryos, respectively). In Experiment 1, we compared the in vitro developmental competence of L1 embryos treated with various concentrations of TSA for different time periods following chemical activation. Embryos treated with 5 nM TSA for 20 h showed a significantly increased blastocyst formation rate compared with untreated controls. In Experiment 2, we examined the effect of TSA (5 nM) treatment of L1, L2 and L3 embryos as well as the effect of treatment of L1, L2 and L3 embryos with various concentrations of SCR on in vitro developmental competence. It was found that 5 nM TSA treatment significantly increased the blastocyst formation rate in L1 and L3 embryos but did not have an influence on the development of L2 embryos. On the other hand, 5 nM SCR treatment significantly increased the blastocyst formation rates of L1 and L2 embryos compared with controls. However, there was no significant increase in the blastocyst formation rate of L3 embryos when they were treated with SCR. In Experiment 3, acetylation of H4K12 was examined in donor cells and pronuclear-stage L1, L2 and L3 embryos treated with 5 nM TSA or 5 nM SCR by immunostaining. The level of H4K12 acetylation was different among donor cells. The staining intensities in the TSA-treated L1 and L3 embryos and SCR-treated L2 embryos were significantly higher than those of untreated embryos. These results suggest that HDACi treatment of bovine SCNT embryos improves the blastocyst formation rate; however, the optimal treatment conditions may differ among donor cell lines. Key words: Bovine, Nuclear transfer, Histone deacetylase inhibitor (J. Reprod. Dev. 57: [120][121][122][123][124][125][126] 2011) ive cloned offspring have been produced in many species by somatic cell nuclear transfer (SCNT), although the cloning efficiency is still very low. It has been reported that, in SCNT, embryo losses occur at various stages, and the anomalies in fetal and perinatal stages have been observed [1] [2] [3] [4] [5] [6] . Because such abnormalities of clones are not transmitted to their progenies [7] [8] [9] [10] [11] [12] , most of the developmental problems of clones are believed to be the results of epigenetic defects [13] . In fact, several studies have revealed abnormal epigenetic modifications such as DNA methylation and histone modifications in SCNT embryos [14] [15] [16] [17] .
(J. Reprod. Dev. 57: 120-126, 2011) ive cloned offspring have been produced in many species by somatic cell nuclear transfer (SCNT), although the cloning efficiency is still very low. It has been reported that, in SCNT, embryo losses occur at various stages, and the anomalies in fetal and perinatal stages have been observed [1] [2] [3] [4] [5] [6] . Because such abnormalities of clones are not transmitted to their progenies [7] [8] [9] [10] [11] [12] , most of the developmental problems of clones are believed to be the results of epigenetic defects [13] . In fact, several studies have revealed abnormal epigenetic modifications such as DNA methylation and histone modifications in SCNT embryos [14] [15] [16] [17] .
A wide variety of histone deacetylase inhibitors (HDACi) of both natural and synthetic origin has been reported [18] . Trichostatin A (TSA), which is a natural product isolated from Streptomyces hygroscopicus [19] , is one of the most frequently used drugs for various studies as a selective HDACi. Recently, it has been reported from two laboratories that TSA treatment of SCNT embryos after NT improves the success rate of mouse cloning [20] [21] [22] . In these reports, treatment with 5 to 100 nM TSA for 9 to 20 h led to a significant increase not only in the blastocyst formation rate, but also in the full-term development rate. In pigs, treatment of SCNT embryos with 37.5 to 50 nM TSA for 24 h significantly improved the blastocyst formation rate [23, 24] . These reports suggest that inhibition of histone deacetylation in SCNT embryos during a short period of culture after NT may promote reprogramming of the donor nucleus.
There are two recent studies on cattle examining the effect of postactivation TSA treatment on the subsequent development of cloned embryos [25, 26] . In contrast to the results in mice and pigs, TSA treatment of cloned bovine embryos after NT did not significantly improve the blastocyst formation rate. However, they used only 5 to 500 nM TSA for 12 h [25] or 13 h [26] for embryo treatment to investigate its effect on the development of SCNT embryos. Furthermore, Iager et al. [26] reported that TSA treatment of bovine cloned embryos improved histone acetylation in the transferred nucleus at the 8-cell stage. This result indicates that TSA treatment of bovine embryos after NT may promote reprogramming of the nucleus. Therefore, in bovine SCNT, it is important to examine the optimal conditions of TSA treatment.
Scriptaid (SCR) is a relatively new synthetic compound that shares a common structure with TSA but has lower toxicity than TSA [27] . Very recently, significant improvements in cloning efficiency of an inbred miniature pigs [28] and inbred mice [29] have been demonstrated using SCR treatment after SCNT. In cattle, however, there has been no report examining the development of SCNT embryos treated with SCR. In the present study, in order to determine the proper exposure time and concentration of TSA and SCR treatment for bovine SCNT embryos, we examined the in vitro developmental competence of bovine embryos treated with various periods or concentrations of TSA and SCR.
Materials and Methods

Donor cells
Three bovine fibroblast cell lines (L1, L2 and L3) were used as somatic cell donors to produce SCNT embryos (L1, L2 and L3 embryos, respectively). Fibroblast cell lines were established as previously described [30, 31] . L1 and L2 were obtained from ear skin tissue of a Japanese black bull (L1) or cow (L2), while L3 was obtained from lung tissue of a female fetus (approximately at 5.5 months of pregnancy). The tissue was chopped finely, and small pieces were seeded in Dulbecco's Modified Eagle's Medium (DMEM, Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS, Tissue Culture Biologicals, Tulare, CA, USA), 100 IU/ml penicillin G potassium (Meiji Seika, Tokyo, Japan) and 100 μg/ml streptomycin (Meiji Seika) under 5% CO2 in air (20% O2) at 38.5 C. The cultured fibroblast cells were frozen and stored at -80 C until use. Before NT, fibroblast cells were serum-starved in DMEM supplemented with 0.5% FBS for 5 to 7 days after reaching approximately 80% confluency.
Recipient oocytes
Ovaries obtained from a slaughterhouse were transported to the laboratory in PBS and stored overnight at 15 C [32] [33] [34] . In Japan, the use of bovine materials, including ovaries, is prohibited by the Abattoir Law until bovine spongiform encephalopathy (BSE) testing results prove negative. Recently, we demonstrated that the storage of ovaries in PBS at 15 C for up to 30 h does not affect embryonic and fetal development after SCNT [35] . Bovine cumulus-oocyte complexes were collected from ovarian follicles of 2-6 mm in diameter and were then cultured in TCM-199 (Gibco BRL, Grand Island, NY, USA) with 10% FBS, 100 IU ml penicillin G potassium and 100 μg/ml streptomycin for 18-20 h under 5% CO2 in air (20% O2) at 38.5 C.
SCNT and embryo culture
The SCNT technique was performed as described previously [32] . Briefly, after in vitro maturation culture, cumulus cells surrounding the oocytes were removed by vortex mixing in 0.1% hyaluronidase for 5 min, and oocytes with a visible first polar body under a dissection microscopy were enucleated. Donor cells were transferred to the perivitelline space of enucleated oocytes. The oocyte-cell complex was sandwiched with a pair of electrodes in Zimmerman mammalian cell fusion medium [36] , and a single direct current pulse of 25 V was applied for 10 μsec for oocyte-cell fusion. The NT embryos were chemically activated 1 h after fusion. Chemical activation was accomplished by treatment with 10 μM calcium ionophore A23187 (Calbiochem-Novabiochem, San Diego, CA, USA) in PBS for 5 min, and 2.5 μg/ml cytochalasin D (Sigma-Aldrich) and 10 μg/ml cycloheximide (SigmaAldrich) in TCM-199 with 10% FBS for 1 h and then 10 μg/ml cycloheximide alone for 4 h. After chemical activation, the NT embryos were cultured in a serum-free medium (IVD 101 [37] , Research Institute for the Functional Peptides, Yamagata, Japan) for 7 days under 5% O2, 5% CO2 and 90% N2 at 38.5 C.
Histone deacetylase inhibitors (HDACi)
TSA (Sigma-Aldrich) or SCR (Sigma-Aldrich) was dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich) and prepared as a 100-fold concentrated stock solution. These stock solutions were added to the activation or culture media at 1:100 dilution according to each experimental procedure. Thus, the final concentration of DMSO was 1% in TSA or SCR treatment media.
Differential staining of blastocysts
Differential staining of the inner cell mass (ICM) and trophectoderm (TE) of blastocysts 7 days after SCNT was performed by the immunosurgery method as described previously [5] . Briefly, blastocysts were treated with 0.5% pronase to remove the zona pellucida. Zona-free embryos were incubated for 10 min in 10 mM trinitrobenzenesulfonic acid (Nakarai Tesque, Kyoto, Japan) in PBS containing 3 mg/ml polyvinylpyrrolidone (Sigma-Aldrich) on crushed ice. The embryos were then incubated for 30 min in TCM-199 containing 0.3 mg/ml anti-dinitrophenol-BSA (Sigma-Aldrich) and for an additional 30 min in TCM-199 containing 20% guinea pig complement (Rockland Immunochemicals, Gilbertsville, PA, USA), 10 μg/ml propidium iodide (Sigma-Aldrich) and 10 μg/ml bisbenzimide (Hoechst 33342, Sigma-Aldrich). After washing in PBS, the embryos were mounted on slides under coverslips and examined under UV light using a fluorescence microscope. This procedure results in blue fluorescence for bisbenzimide-stained ICM nuclei and pink fluorescence for TE nuclei stained with both fluorochromes.
Detection of acetylated histone
Rabbit anti-acetyl-histone H4 at lysine 12 (H4K12, Upstate, Millipore, Billerica, MA, USA; 1:125 dilution) was used as a primary antibody. L1, L2 and L3 cells and SCNT embryos were washed with PBS, fixed in 4% paraformaldehyde in PBS for 20 min, permeabilized with 0.1% Triton X-100 in PBS for 20 min and blocked overnight with 1% bovine serum albumin and 0.1% Triton X-100 in PBS at 4 C. The primary antibody was detected by a goat anti-rabbit secondary antibody coupled with fluorescein isothiocyanate (FITC; Sigma-Aldrich; 1:250 dilution). The nuclei were counterstained with Hoechst 33342. They were then inspected under a fluorescent microscope using excitation filters at 450-490 nm for FITC and 365 nm for Hoechst. Images were obtained with the same exposure times and adjustments of the microscope. The fluorescence intensity was analyzed using the ImageJ software (National Institutes of Health, Bethesda, MD, USA). The fluorescence intensity was measured by manually outlining all nuclei in the display. Two cytoplasmic regions were also outlined for normalization to the background [26] . The fluorescence intensity was determined by dividing the signal intensity of each nucleus by the mean cytoplasmic signal intensity [26] .
Experimental design
Experiment 1: The effect of TSA treatment on the in vitro development of L1 embryos was examined. First, we compared the in vitro developmental competence of L1 embryos treated with 5 nM [20] for different time periods (5, 10, 20 and 40 h) following chemical activation. Also, L1 embryos were cultured in media without TSA and DMSO as a control group. The experiments were repeated four times. Secondly, the in vitro developmental competences of L1 embryos treated with various concentration (500 pM, 5 nM, 50 nM, 500 nM and 5 μM) of TSA for 20 h were examined.
Other sets of embryos were cultured in media without TSA, but with 1% DMSO (a vehicle control group) or without DMSO for 20 h as a control group. The experiments were repeated seven times.
Experiment 2: We investigated whether TSA treatment at a concentration of 5 nM, which was proven to be effective for development of L1 embryos in Experiment 1, was effective for L2 and L3 embryos. Also, the effect of SCR treatment at various concentrations (5, 50 and 500 nM) on the in vitro development of L1, L2 and L3 embryos was examined. The embryos were treated with SCR or TSA for 20 h following chemical activation. As a control group, embryos were cultured in media without SCR, TSA and DMSO. The experiments were repeated at least four times in each treatment.
Experiment 3: Acetylation of H4K12 was examined in donor cells and L1, L2 and L3 embryos at the pronuclear stage (5 h after activation). The cells of passages 3 to 5 were serum-starved in DMEM supplemented with 0.5% FBS for 5 to 7 days after reaching approximately 80% confluency and used for detection of acetylated histone. The experiments were repeated seven times. The SCNT embryos were treated with 5 nM TSA or 5 nM SCR for 5 h after activation. SCNT embryos without TSA and SCR treatment were used as a control group. The experiments were repeated three times with 3 embryos per group.
Statistical analysis
Cleavage and development rates of the embryos were compared by the Chi-square test. Data for blastocyst cell number, ICM ratio and relative levels of H4K12 acetylation of SCNT embryos were analyzed using Dunnett's test. Data for relative levels of H4K12 acetylation of donor cells were analyzed using the Tukey-Kramer multiple comparison test. A value of P < 0.05 was considered to be significant.
Results
Experiment 1
As shown in Table 1 , treatment of L1 embryos with 5 nM TSA for 5 to 40 h did not significantly influence their cleavage rates. However, TSA treatment for 20 h increased the blastocyst formation rate (31%) compared with the control (16%; P<0.05). The total cell number and ICM ratio in blastocysts obtained from L1 embryos treated with 5 nM TSA for 5 to 40 h were similar to those of the untreated control group.
The in vitro development rates of L1 embryos treated with various concentrations of TSA for 20 h are shown in Table 2 . There was no significant difference in the cleavage rates between the TSA-treated and untreated embryos. Treatment with 1% DMSO (a vehicle control group) for 20 h did not affect the in vitro development rate to the blastocyst stage; the rates for the vehicle control and untreated control groups were the same (16%). The blastocyst formation rate of the L1 embryos treated with 5 nM TSA (29%) was significantly higher than that of the control (16%; P<0.05). On the other hand, treatment with 5 μM TSA produced a slight decrease in the blastocyst formation rate (7%; P<0.08). There was no significant difference in the cell numbers of blastocysts and the ICM ratio between the TSA-treated and untreated embryos.
Experiment 2
As shown in Fig. 1 , when L2 and L3 embryos were treated with 5 nM TSA, L3 embryos had a significantly higher blastocyst formation rate (19/50, 38%) compared with that of the control group (7/55, 12%; P<0.05), however, the treatment had no effect on the rate of L2 embryos (42/133, 32%, control:58/196, 30%). When L1, L2 and L3 embryos were treated with various concentrations of SCR, 5 nM SCR significantly increased the blastocyst formation rates of L1 and L2 embryos (24/60, 40% and 37/80, 46%, respectively) compared with those of the untreated embryos (15/65, 23%, and 58/196, 30%, respectively). Also, treatment with 500 nM SCR resulted in a significantly higher blastocyst formation rate in L2 embryos (33/72, 46%) compared with that of the control embryos (58/196, 30%). In contrast, treatment with 50 nM SCR had no effect on the blastocyst formation rate, irrespective of the source of the donor somatic cells. The development of the L3 embryos was not affected by any concentration of SCR. As shown in Fig. 2 , treatment with 5 to 500 nM SCR or 5 nM TSA did not significantly affect the total cell numbers of blastocysts or the ICM ratio.
Experiment 3
As shown in Figs. 3 and 4 , the level of H4K12 acetylation was different among the donor cell lines. Most of the L3 cells had higher intensities of staining (Fig. 3) . As shown in Figs. 3 and 5, when H4K12 acetylation was examined in the TSA-treated, SCRtreated or untreated L1, L2 or L3 embryos at the pronuclear stage, the staining intensities were significantly higher in the TSA-treated L1 and L3 embryos and SCR-treated L2 embryos compared with the control embryos (P<0.05; Fig. 5 ).
Discussion
TSA treatment of SCNT embryos has been reported to be effective for improving the blastocyst formation rate in mice [20] [21] [22] 38] and pigs [23, 24] . In contrast, when bovine SCNT embryos were treated with TSA at 50 nM for 13 h [26] and at 5, 50 or 500 nM for 12 h [25] after NT, no significant effects on the development to the blastocyst stage were observed. In these reports, however, only one cell line was used as a nuclear donor in each experiment, and it remains to be determined whether TSA treatment is effective in other cell lines. In the present study, therefore, we used three types of fibroblast cell lines (L1, L2 and L3) as NT donors. We found that, consistent with the results in mice and pigs, TSA treatment increased the blastocyst formation rate in L1 and L3 embryos. In L2 embryos, although in vitro development was not affected by TSA treatment, another HDACi, SCR, improved the blastocyst for- mation rate. It is of interest that a recent report found that the in vitro development of bovine SCNT embryos was enhanced by treatments of both donor cells and embryos with TSA [25] . Together with the results in this study, HDACi treatment seems to improve the development of cloned bovine embryos if used under appropriate conditions. However, how HDACi treatment enhances the developmental competence of NT embryos remains unclear. One possible explanation is that HDACi treatment of NT embryos may lead to amendment of abnormal epigenetic modifications, followed by normal expression of some development-related genes. Recent reports have demonstrated that TSA treatment of murine NT embryos influences the expression of genes that regulate chromatin structure and DNA methylation at the blastocyst stage [38] and that the histone acetylation levels of TSA-treated NT embryos are more similar to those of in vitro fertilized embryos than those of untreated cloned embryos in cattle [26] . In addition, Shao et al. reported that TSA treatment of mouse SCNT embryos enhances the expression of two embryonic genes shown to be transcriptionally active during zygotic gene activation (ZGA) [39] . In cattle, the timing and uniformity of ZGA affect the subsequent preimplantation development of SCNT embryos [40] . Therefore, HDACi treatment may lead to precise and uniform embryonic gene expression of SCNT embryos and subsequently to increase in the developmental ability to the blastocyst stage [40] . However, since it is not clear whether HDACi treatment of bovine SCNT embryos affects embryonic gene expression, further research is required.
We examined the optimal exposure time and concentration of TSA treatment for L1 embryos. As a result, treatment of embryos with 5 nM TSA for 20 h after chemical activation improved the developmental competence to the blastocyst stage. However, when L2 was used as the donor, the same treatment had no effect on in vitro development. A recent study also showed no significant improvement in in vitro development of bovine NT embryos that were treated with 50 nM TSA for 13 h [26] . The authors of that study suggested that it was because development to the blastocyst stage is often low in murine NT, allowing room for improvement, while the bovine cloned blastocyst rate is already close to that of IVF (NT vs. IVF = 30 vs. 24% in the study of Iager et al. [26] ). Indeed, in the present study, the blastocyst formation rate of control NT embryos from L2, in which no significant improvement was observed by TSA treatment, was significantly higher (30%) than those from L1 (16%) and L3 (13%). However, the treatment with another HDACi, SCR, was able to enhance blastocyst formation rate to 46%. These results suggest that the optimal conditions for TSA treatment of cloned embryos after NT may be different according to the donor cell line used. In bovine SCNT, TSA is also used for treatment of donor cells in order to improve the developmental competence of NT embryos [41, 42] . Donor fibroblast cells treated with low doses of TSA such as 50 nM [25] or 80 nM [41] have shown improvements in blastocyst formation rate. On the other hand, when fibroblast cells are treated with higher doses of TSA, the effect on the development competence of the resultant NT embryos is different among reports. In the report by Shi et al. [43] , the in vitro development of NT embryos from fetal fibroblast cells treated with 0.99 μM TSA was similar to that of untreated controls.
However, in the report by Wee et al. [42] , embryos cloned from adult fibroblast cells treated with 1 μM TSA had a significantly higher blastocyst formation rate than that of untreated controls, while in the report by Enright et al. [40] , embryos from adult fibroblast cells treated with 1.25 μM TSA had a significantly lower developmental competence than that of controls. These discrepancies may be attributed to the epigenetic states of donor cells used for NT in each study because the levels of DNA methylation and histone acetylation of bovine fibroblasts vary depending on the in vitro culture systems used [44] [45] [46] . In the present study, the level of histone acetylation differed among the cell lines used, as shown in Fig. 4 , suggesting the possibility that the epigenetic state of the donor cells influences the effect of TSA treatment after NT on the developmental competence of embryos in cattle.
In mouse SCNT, TSA treatment led to an increase of the level of H4K12 acetylation 3 h after NT and an improvement of cloning efficiency [21] . We examined the level of H4K12 acetylation in NT embryos at the pronuclear stage (5 h after chemical activation). In the L1 embryos, the treatment with 5 nM SCR had no effect on H4K12 acetylation. However, this treatment led to improvements in in vitro developmental competence. It has been reported that the level of histone H4 acetylation of bovine SCNT embryos at the pronuclear stage is low [47] . Also, in rabbit SCNT, the level of H4K12 acetylation increases during pronuclear development [48] . In the present study, it may have been difficult to detect the difference of H4K12 acetylation because the level of histone acetylation was very low at the early pronuclear stage. In porcine SCNT, TSA treatment, which improves in vitro development, does not affect H4K16 and H3K9 acetylation at 4 h after activation, but TSAtreated embryos show a higher intensity of acetylated H4K16 and H3K9 than untreated embryos at the 2-cell stage [24] . Iager et al. [26] demonstrated that TSA treatment of bovine NT embryos increases the level of H4K5 acetylation compared with untreated embryos at the 8-cell stage. In the present study, there is a possibility that treatment with 5 nM SCR affected the histone acetylation of embryos after the 2-cell stage. Therefore, further examination of histone acetylation in HDACi-treated and untreated SCNT embryos at various developmental stages is required.
In the present study, we used TSA and SCR to inhibit HDAC in bovine SCNT embryos. TSA is a natural product isolated from Streptomyces hygroscopicus [19] , while SCR is a synthetic compound. Although both inhibitors belong to the class of hydroxamic acid-containing HDACi, Su et al. [27] demonstrated that SCR is a potent HDACi with lower toxicity than TSA. In the present study, we compared the in vitro developmental competence of NT embryos treated with TSA or SCR. However, we could not demonstrate which HDACi was more suitable for improving the developmental competence of NT embryos because the effects of TSA and SCR on the in vitro developmental competence of SCNT embryos were different among the cell lines. Both of the HDACi treatments significantly improved the in vitro developmental competence of the L1 embryos only. In the present study, the blastocyst formation rate of the L1 embryos increased by almost the same extent with TSA or SCR treatment compared with the respective control embryos [1.8-1.9 times higher with TSA compared with the control (Tables 1 and 2 ), 1.8 times higher with SCR compared with the control (Fig. 1)] . These results suggest that TSA and SCR may have similar effects in improving the in vitro developmental competence of SCNT embryos, if the embryos are treated under the proper conditions. However, evaluation of the in vivo developmental competence of the embryos after embryo transfer is necessary to ascertain which HDACi is suitable for improving the cloning efficiency.
In conclusion, our data suggest that HDACi, TSA or SCR, treatment of bovine SCNT embryos improves the blastocyst formation rate. However, since the optimal treatment conditions may differ for different donor cell lines, it is necessary to investigate the optimal exposure time and concentration of HDACi in each cell line used as an NT donor.
